Title:
β−セクレターゼ阻害剤
Document Type and Number:
Japanese Patent JP5731414
Kind Code:
B2
Abstract:
The present invention is directed to a compound represented by the following structural formula
or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and method of use of the compounds are also described.
More Like This:
Inventors:
Kakatian, Salvation
Claremon, David A
Dillard, Lawrence W
Fox, claus
Heine, Niclas
Ja ranchi
Lef Salis, Katerina
Brian McKieber
Morales-Ramos, Angel
Shin, Suresh
Venkatlaman, Shankar
Wu, Guo Shen
Woo, John Ren
Shu, Zenron
Yuan, gin
Chen, Yajun
Claremon, David A
Dillard, Lawrence W
Fox, claus
Heine, Niclas
Ja ranchi
Lef Salis, Katerina
Brian McKieber
Morales-Ramos, Angel
Shin, Suresh
Venkatlaman, Shankar
Wu, Guo Shen
Woo, John Ren
Shu, Zenron
Yuan, gin
Chen, Yajun
Application Number:
JP2011554237A
Publication Date:
June 10, 2015
Filing Date:
March 12, 2010
Export Citation:
Assignee:
Vity Pharmaceuticals, Inc.
Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH
International Classes:
C07D235/02; A61K31/4184; A61K31/4188; A61K31/4245; A61K31/427; A61K31/428; A61K31/4439; A61K31/454; A61K31/497; A61K31/501; A61K31/5025; A61K31/527; A61K31/5395; A61K31/5415; A61P9/00; A61P25/00; A61P25/28; A61P27/06; A61P43/00; C07D239/70; C07D271/12; C07D273/04; C07D277/60; C07D279/08; C07D401/04; C07D401/06; C07D403/04; C07D403/06; C07D405/06; C07D413/06; C07D417/04; C07D417/06; C07D417/10; C07D491/10; C07D491/20; C07D498/10; C07D513/10
Domestic Patent References:
JP2012502112A | ||||
JP2008523059A | ||||
JP2007513973A | ||||
JP10500112A | ||||
JP2009502294A | ||||
JP2008503459A |
Foreign References:
WO2010021680A1 | ||||
WO2008103351A1 | ||||
WO2008133273A1 | ||||
WO2008010481A1 |
Attorney, Agent or Firm:
Hajime Tsukuni
Keiko Ozawa
Keiko Ozawa